Company News

Zelluna Immunotherapy appoints Chief Financial Officer CGT Catapult appoints new board members Clinipace’s growth supported by new executive leadership Crescendo Biologics appoints Dr Richard Williams STEM Healthcare appoints new CEO New head for Liquid Purification Technologies business unit IVF innovator appoints new Chief Scientific Officer F-star appoints Dr Eliot Forster as CEO Servomex appoints new VP of Sales for the Americas Cerecin appoints two new members to its Scientific Advisory board Bionure appoints Dr Laurent Nguyen as CEO SenzaGen recruits Business Development Director International Biomedical Research Alliance makes new appointment Dr Korpman will provide mentorship to PhD and MD/PhD students in the US and UK and is a recognised pioneer in the medical informatics field Clariant welcomes Hans Bohnen Aglaris appoints new CEO Aigenpulse appoints Chief Product Officer

Trending Articles

  1. Alfa Laval appoints new managing director to drive strategic growth Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
  2. How strong leadership transforms regulatory and operational challenges Why SLTs fail on the PQS/QMS: The leadership gap undermining quality
  3. Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
  4. Kindeva appoints Brok Weichbrodt as Chief Transformation Officer to accelerate growth strategy and commercial excellence Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan
  5. Medicines Discovery Catapult selects prominent UK life sciences leader, Professor Sir Mike Ferguson, as its incoming Chair of the Board MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all